{"id":"https://openalex.org/W2064596734","doi":"https://doi.org/10.1177/0269881109354928","title":"Preclinical and clinical pharmacology of TPA023B, a GABA A receptor \u03b12/\u03b13 subtype-selective partial agonist","display_name":"Preclinical and clinical pharmacology of TPA023B, a GABA A receptor \u03b12/\u03b13 subtype-selective partial agonist","alternate_titles":[],"publication_year":2010,"publication_date":"2010-02-15","ids":{"openalex":"https://openalex.org/W2064596734","doi":"https://doi.org/10.1177/0269881109354928","mag":"2064596734","pmid":"https://pubmed.ncbi.nlm.nih.gov/20156926"},"language":"en","primary_location":{"id":"doi:10.1177/0269881109354928","doi":"https://doi.org/10.1177/0269881109354928","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881109354928","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2064596734"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pubmed.ncbi.nlm.nih.gov/20156926","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027021273","display_name":"John R. Atack","orcid":"https://orcid.org/0000-0002-3410-791X","observed_orcids":["https://orcid.org/0000-0002-3410-791X"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"JR Atack","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022416943","display_name":"David J. Hallett","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"DJ Hallett","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007123075","display_name":"Spencer J. Tye","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S Tye","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072439028","display_name":"Keith A. Wafford","orcid":"https://orcid.org/0000-0002-8508-4738","observed_orcids":["https://orcid.org/0000-0002-8508-4738","https://orcid.org/0000-0003-4537-4690"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"KA Wafford","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"C Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C Ryan","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083649504","display_name":"Sandra M. Sanabria Bohorquez","orcid":"https://orcid.org/0000-0003-2890-2076","observed_orcids":["https://orcid.org/0000-0003-2890-2076"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SM Sanabria-Boh\u00f3rquez","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065100819","display_name":"Waisi Eng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wai-si Eng","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113623433","display_name":"RE Gibson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RE Gibson","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111855647","display_name":"H. Donald Burns","orcid":"https://orcid.org/0000-0002-6425-2173","observed_orcids":["https://orcid.org/0000-0002-6425-2173"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"HD Burns","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025285378","display_name":"Gerry R. Dawson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"GR Dawson","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080950417","display_name":"Robert W. Carling","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"RW Carling","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112779115","display_name":"L O N D O N Gower Street","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"LJ Street","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005150760","display_name":"Andy Pike","orcid":"https://orcid.org/0000-0001-6078-7501","observed_orcids":["https://orcid.org/0000-0001-6078-7501"]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Pike","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112425516","display_name":"Inge De Lepeleire","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210121359","display_name":"MSD (Belgium)","ror":"https://ror.org/02j4p4h77","country_code":"BE","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210121359"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"I De Lepeleire","raw_affiliation_strings":["Clinical Pharmacology, Merck Sharp & Dohme Research Laboratories, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Merck Sharp & Dohme Research Laboratories, Brussels, Belgium","institution_ids":["https://openalex.org/I4210121359"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081304921","display_name":"Koen Van Laere","orcid":"https://orcid.org/0000-0001-5200-7245","observed_orcids":["https://orcid.org/0000-0001-5200-7245"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"K Van Laere","raw_affiliation_strings":["Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072600244","display_name":"Guy M Bormans","orcid":"https://orcid.org/0000-0002-0335-7190","observed_orcids":["https://orcid.org/0000-0002-0335-7190"]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"G Bormans","raw_affiliation_strings":["Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Nuclear Medicine and Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Nuclear Medicine and#R# Radiopharmacy, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112025857","display_name":"JN de Hoon","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"JN de Hoon","raw_affiliation_strings":["Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111609771","display_name":"Anne Van Hecken","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"A Van Hecken","raw_affiliation_strings":["Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacology, Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]},{"raw_affiliation_string":"Department of Clinical Pharmacology,#R# Katholieke Universiteit Leuven, Leuven, Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109943677","display_name":"Ruth M. McKernan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087189","display_name":"MSD (UK) Limited (United Kingdom)","ror":"https://ror.org/004nn4n27","country_code":"GB","type":"company","lineage":["https://openalex.org/I1285764155","https://openalex.org/I4210087189"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"RM McKernan","raw_affiliation_strings":["Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp & Dohme Research Laboratories, Harlow, UK","institution_ids":["https://openalex.org/I4210087189"]},{"raw_affiliation_string":"Neuroscience Research Centre, Merck Sharp and Dohme Research Laboratories, Harlow, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108487972","display_name":"MG Murphy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"MG Murphy","raw_affiliation_strings":["Clinical Pharmacology, Merck Research Laboratories, Bluebell, PA, USA","Clinical Pharmacology, Merck Research#R# Laboratories, Bluebell, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology, Merck Research Laboratories, Bluebell, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Clinical Pharmacology, Merck Research#R# Laboratories, Bluebell, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110221578","display_name":"Richard J Hargreaves","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"RJ Hargreaves","raw_affiliation_strings":["Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"Imaging Research and Pharmacology, Merck Research#R# Laboratories, West Point, PA, USA","institution_ids":["https://openalex.org/I1285764155"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5027021273"],"corresponding_institution_ids":["https://openalex.org/I4210087189"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":1.5223,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.78786242,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"25","issue":"3","first_page":"329","last_page":"344"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13047","display_name":"Pharmacological Receptor Mechanisms and Effects","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gaba-a-receptor","display_name":"GABAA receptor","score":0.8199999928474426},{"id":"https://openalex.org/keywords/partial-agonists","display_name":"partial agonists","score":0.906000018119812},{"id":"https://openalex.org/keywords/receptor-occupancy","display_name":"receptor occupancy","score":0.7720000147819519},{"id":"https://openalex.org/keywords/sedation","display_name":"sedation","score":0.8640000224113464},{"id":"https://openalex.org/keywords/anxiolytic-effects","display_name":"anxiolytic effects","score":0.8619999885559082},{"id":"https://openalex.org/keywords/flumazenil-binding","display_name":"flumazenil binding","score":0.6959999799728394},{"id":"https://openalex.org/keywords/ataxia","display_name":"ataxia","score":0.49399998784065247},{"id":"https://openalex.org/keywords/myorelaxation","display_name":"myorelaxation","score":0.9670000076293945},{"id":"https://openalex.org/keywords/squirrel-monkey","display_name":"squirrel monkey","score":0.35899999737739563},{"id":"https://openalex.org/keywords/baboons","display_name":"baboons","score":0.6629999876022339},{"id":"https://openalex.org/keywords/clinical-pharmacology","display_name":"clinical pharmacology","score":0.5149999856948853}],"concepts":[{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.8084604740142822},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.7799842357635498},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.7064006924629211},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6882564425468445},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.5370485186576843},{"id":"https://openalex.org/C2776814716","wikidata":"https://www.wikidata.org/wiki/Q574801","display_name":"Sedation","level":2,"score":0.4795396327972412},{"id":"https://openalex.org/C2779594886","wikidata":"https://www.wikidata.org/wiki/Q159429","display_name":"Baboon","level":2,"score":0.4724952280521393},{"id":"https://openalex.org/C173586616","wikidata":"https://www.wikidata.org/wiki/Q5359685","display_name":"Elevated plus maze","level":3,"score":0.4719735085964203},{"id":"https://openalex.org/C2776030879","wikidata":"https://www.wikidata.org/wiki/Q309200","display_name":"Squirrel monkey","level":2,"score":0.45404186844825745},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.45273417234420776},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.43143704533576965},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4292190968990326},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.42271292209625244},{"id":"https://openalex.org/C2778914748","wikidata":"https://www.wikidata.org/wiki/Q10850","display_name":"Rodent","level":2,"score":0.4209633469581604},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36463040113449097},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3485412001609802},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27378103137016296},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24974754452705383},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.19447731971740723},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.12789291143417358},{"id":"https://openalex.org/C18903297","wikidata":"https://www.wikidata.org/wiki/Q7150","display_name":"Ecology","level":1,"score":0.0},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001007","descriptor_name":"Anxiety","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006576","descriptor_name":"Heterocyclic Compounds, 4 or More Rings","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006845","descriptor_name":"Hydrocarbons, Fluorinated","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011963","descriptor_name":"Receptors, GABA-A","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D012453","descriptor_name":"Saimiri","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013045","descriptor_name":"Species Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021122","descriptor_name":"Protein Subunits","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D058785","descriptor_name":"GABA-A Receptor Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1177/0269881109354928","doi":"https://doi.org/10.1177/0269881109354928","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0269881109354928","pdf_url":null,"source":{"id":"https://openalex.org/S136368880","display_name":"Journal of Psychopharmacology","issn_l":"0269-8811","issn":["0269-8811","1461-7285"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:20156926","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20156926","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of psychopharmacology (Oxford, England)","raw_type":"Controlled Clinical Trial"},{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/261361","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20156926","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology, vol. 25 (3), (329-344)","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:105895","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/105895/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:lirias2repo.kuleuven.be:123456789/261361","doi":null,"is_oa":true,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20156926","pdf_url":null,"source":{"id":"https://openalex.org/S7407055369","display_name":"Lirias","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Psychopharmacology, vol. 25 (3), (329-344)","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":45,"referenced_works":["https://openalex.org/W1520508152","https://openalex.org/W1565551672","https://openalex.org/W1977614408","https://openalex.org/W2001619275","https://openalex.org/W2007446108","https://openalex.org/W2008215214","https://openalex.org/W2010504165","https://openalex.org/W2011606970","https://openalex.org/W2014376010","https://openalex.org/W2016154588","https://openalex.org/W2016652516","https://openalex.org/W2022378061","https://openalex.org/W2033853536","https://openalex.org/W2056548197","https://openalex.org/W2060402638","https://openalex.org/W2061688783","https://openalex.org/W2061691777","https://openalex.org/W2062186332","https://openalex.org/W2065964876","https://openalex.org/W2070997142","https://openalex.org/W2071973373","https://openalex.org/W2083623577","https://openalex.org/W2090116461","https://openalex.org/W2090851348","https://openalex.org/W2092484618","https://openalex.org/W2095043290","https://openalex.org/W2100216728","https://openalex.org/W2106257034","https://openalex.org/W2106607972","https://openalex.org/W2106915249","https://openalex.org/W2112805640","https://openalex.org/W2116251480","https://openalex.org/W2121060688","https://openalex.org/W2121237571","https://openalex.org/W2129874579","https://openalex.org/W2139674907","https://openalex.org/W2143086898","https://openalex.org/W2147612834","https://openalex.org/W2148815807","https://openalex.org/W2151414518","https://openalex.org/W2203342607","https://openalex.org/W2404476850","https://openalex.org/W2565783397","https://openalex.org/W4246109793","https://openalex.org/W4406059090"],"related_works":["https://openalex.org/W4246109793","https://openalex.org/W41628817","https://openalex.org/W2044558761","https://openalex.org/W2121060688","https://openalex.org/W1520508152","https://openalex.org/W2008215214","https://openalex.org/W2133671844","https://openalex.org/W2060402638","https://openalex.org/W2007446108"],"abstract_inverted_index":{"In":[0,198],"the":[1,33,41,56,66,114,216,225,233,238],"accompanying":[2],"paper":[3],"we":[4,39],"describe":[5],"how":[6],"MRK-409":[7,71,221],"unexpectedly":[8],"produced":[9,210],"sedation":[10,29,217,251],"in":[11,91,123,132,147,173,252],"man":[12,135],"at":[13,55,65,69,204,232,243],"relatively":[14],"low":[15],"levels":[16],"of":[17,43,82,108,116,154,163,178,194,212,229,240],"GABA(A)":[18,37,85,246],"receptor":[19,247],"occupancy":[20,81,98,193,211],"(\u223c10%).":[21],"Since":[22],"it":[23],"was":[24,30,118,145,201],"not":[25],"clear":[26],"whether":[27],"this":[28,244],"mediated":[31],"via":[32],"\u03b12/\u03b13":[34],"or":[35,175],"\u03b11":[36,67,234],"subtype(s),":[38],"characterized":[40],"properties":[42],"TPA023B,":[44],"a":[45,101,205],"high-affinity":[46],"imidazotriazine":[47],"which,":[48],"like":[49],"MRK-409,":[50],"has":[51,72],"partial":[52,74,226],"agonist":[53,227],"efficacy":[54,228,242],"\u03b12":[57],"and":[58,79,104,111,127,134,140,149,236],"\u03b13":[59],"subtype":[60],"but":[61],"is":[62,222],"an":[63,90],"antagonist":[64,241],"subtype,":[68,235],"which":[70,117],"weak":[73],"agonism.":[75],"TPA023B":[76,144,200],"gave":[77],"dose-":[78],"time-dependent":[80],"rat":[83],"brain":[84],"receptors":[86],"as":[87],"measured":[88],"using":[89,136],"vivo":[92],"[(3)H]flumazenil":[93],"binding":[94],"assay,":[95],"with":[96,220],"50%":[97],"corresponding":[99,191],"to":[100,120,129,187,192,224],"respective":[102],"dose":[103,206],"plasma":[105],"drug":[106],"concentration":[107],"0.09":[109],"mg/kg":[110],"19":[112],"ng/mL,":[113,142],"latter":[115],"similar":[119],"that":[121,209,215,230],"observed":[122],"mice":[124],"(25":[125],"ng/mL)":[126],"comparable":[128],"values":[130],"obtained":[131],"baboon":[133],"[(11)C]flumazenil":[137],"PET":[138],"(10":[139,189],"5.8":[141],"respectively).":[143],"anxiolytic":[146],"rodent":[148,174],"primate":[150,176],"(squirrel":[151],"monkey)":[152],"models":[153],"anxiety":[155],"(elevated":[156],"plus":[157],"maze,":[158],"fear-potentiated":[159],"startle,":[160],"conditioned":[161,165],"suppression":[162],"drinking,":[164],"emotional":[166],"response)":[167],"yet":[168],"had":[169],"no":[170],"significant":[171],"effects":[172],"assays":[177],"ataxia":[179],"and/or":[180],"myorelaxation":[181],"(rotarod,":[182],"chain-pulling,":[183],"lever":[184],"pressing),":[185],"up":[186],"doses":[188],"mg/kg)":[190],"greater":[195],"than":[196],"99%.":[197],"man,":[199],"well":[202],"tolerated":[203],"(1.5":[207],"mg)":[208],">50%,":[213],"suggesting":[214],"previously":[218],"seen":[219],"due":[223],"compound":[231],"highlighting":[237],"importance":[239],"particular":[245],"population":[248],"for":[249],"avoiding":[250],"man.":[253]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2064596734","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
